# Acadia Healthcare Company, Inc. (ACHC)

> Source: Nexqual · https://nexqual.com/ACHC · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Acadia Healthcare Company, Inc. (ACHC), nexqual.com/ACHC" · informational, not investment advice.

**Price:** USD 31.88 (+1.43% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 31.43 · day 31.05–32.2 · 52w 11.43–35.83 · market cap $2.97B · NMS

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $3.37B, net income -$1.13B (-33.4% margin), free cash flow -$134M (SEC filings).
- 2 of 80 tracked superinvestors hold ACHC (13F, Q2 2026): 0 new, 0 added, 2 reduced, 0 unchanged.
- Analysts: Buy (mean 2.43 on a 1–5 scale) (14 analysts), mean target USD 33.79 (range 17–41).
- Total return with dividends: 1Y +35.7% vs S&P 500 +14.9%; 5Y -44.8% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.46, revenue estimate $878M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $2.31B | $2.61B | $2.93B | $3.15B | $3.31B | $3.37B |
| Net income | $191M | $273M | -$21.7M | $256M | -$1.10B | -$1.13B |
| EPS (diluted) | $2.10 | $2.98 | -$0.24 | $2.78 | -$12.16 | — |
| Free cash flow | $130M | $84.4M | $38.2M | -$561M | -$440M | -$134M |
| Net margin | 8.2% | 10.5% | -0.7% | 8.1% | -33.3% | -33.4% |
| Revenue growth | +10.7% | +12.8% | +12.2% | +7.7% | +5.0% | — |
| Cash + short-term investments | $134M | $97.6M | $100M | $76.3M | $133M | — |
| Total debt | $1.50B | $1.39B | $1.37B | $1.96B | $2.50B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/S 0.9x · EV/Sales 1.6x · P/B 1.5x · FCF yield -4.52% · Earnings yield -37.95% · Net debt $2.24B · EV $5.21B
P/E at fiscal year-ends: Dec 2024 14.3x.

## Superinvestors (SEC 13F-HR, Q2 2026)
2 of 80 tracked investors hold ACHC. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Abrams Bison Investments, LLC |  | 6.00% | $123M | Reduced -4.9% |
| David Einhorn | Greenlight Capital | 3.32% | $130M | Reduced -2.6% |

## Analysts
Consensus Buy (mean 2.43 on a 1–5 scale), 14 analysts; mean target USD 33.79 (low 17, high 41).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-23 | Leerink Partners | Target raised | Market Perform | $30 → $33 |
| 2026-07-30 | Guggenheim | Target raised | Buy | $38 → $39 |
| 2026-07-30 | Barclays | Target raised | Equal-Weight | $25 → $32 |
| 2026-07-20 | Guggenheim | Target raised | Buy | $31 → $38 |
| 2026-07-14 | TD Cowen | Target raised | Buy | $30 → $36 |
| 2026-07-14 | Keybanc | Target raised | Overweight | $30 → $40 |
| 2026-07-09 | UBS | Target raised | Buy | $31 → $39 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +35.7% | -44.8% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +35.8% | -11.2% |
| Volatility (annualized) | 64.1% | 47.6% |
| Max drawdown | -50.3% (Oct 2025→Jan 2026) | -86.6% (Nov 2022→Jan 2026) |

## Peers (Medical Care Facilities)
AVAH (Aveanna Healthcare Holdings Inc) USD 13.32 +2.54% · GRDN (Guardian Pharmacy Services, Inc) USD 39.59 +1.56% · BKD (Brookdale Senior Living Inc.) USD 10.19 +1.09% · MD (Pediatrix Medical Group, Inc.) USD 29.55 +5.16% · NHC (National HealthCare Corporation) USD 243.07 +3.17% · ADUS (Addus HomeCare Corporation) USD 122.67 +4.00%

## More
Full page: https://nexqual.com/ACHC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in ACHC's own 10-K filed 2026-02-27 (https://www.sec.gov/Archives/edgar/data/1520697/000119312526078266/achc-20251231.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Ford (F) | "The five joint venture facilities opened during the year ended December 31, 2025, were through partnerships with Henry Ford Health, Geisinger Health, Ascension Seton, Fairview Health Services, and ECU Health." |

## Revenue by product line (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Acute Inpatient Psychiatric Facilities | $494.6M | 57.1% | -0.2% |
| Comprehensive Treatment Centers | $141.2M | 16.3% | -0.2% |
| Specialty Treatment Facilities | $133.5M | 15.4% | -8.4% |
| Residential Treatment Centers | $96.6M | 11.2% | +11.6% |
| Total revenue | $865.8M | 100% | — |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.46 | $0.48 | -3.9% | $877.8M | 12 |
| Next quarter (ends 2026-12-31) | $0.33 | $0.30 | +9.4% | $855.6M | 12 |
| Current fiscal year (ends 2026-12-31) | $1.55 | $1.52 | +2.4% | $3.43B | 13 |
| Next fiscal year (ends 2027-12-31) | $1.85 | $1.75 | +5.6% | $3.63B | 13 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-11-04): ±16.9%; last 8 reports averaged ±15.1%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 74.9% | ±16.9% |
| 2026-12-18 | 56 | 59.3% | ±18.8% |
| 2027-01-15 | 84 | 54.2% | ±20.5% |
| 2027-03-19 | 147 | 55.7% | ±27.6% |
| 2027-06-17 | 237 | 58.5% | ±35.9% |